Cancer Imaging Tech Forum May Lead To Further FDA/CMS Collaboration
This article was originally published in The Gray Sheet
Executive Summary
The National Cancer Institute's Interagency Council on Biomedical Imaging in Oncology has had 36 requests for meetings with manufacturers and researchers since its inception in June 2000
You may also be interested in...
FDA Tags Academic Researcher To Probe Advisory Panel Conflicts Of Interest
A joint conflict-of-interest study by FDA and the University of Maryland will survey attendees at the agency's April Circulatory System Devices Advisory Panel and National Mammography Quality Assurance Advisory Committee meetings, according to the project's primary investigator
FDA Tags Academic Researcher To Probe Advisory Panel Conflicts Of Interest
A joint conflict-of-interest study by FDA and the University of Maryland will survey attendees at the agency's April Circulatory System Devices Advisory Panel and National Mammography Quality Assurance Advisory Committee meetings, according to the project's primary investigator
FDA Review Criteria Are Insufficient To Prompt CMS Coverage – Feigal, Tunis
Proposals allowing FDA's approval criteria to play a greater role in Medicare coverage determinations should account for the fact that many devices are cleared via 510(k) and not reviewed for clinical effectiveness, CDRH Director David Feigal asserted Oct. 11